Traws Pharma GAAP EPS of -$0.34
Source: SeekingAlpha
2025-11-13 07:23:29 ET
More on Traws Pharma
Read the full article on Seeking Alpha
For further details see:
Traws Pharma GAAP EPS of -$0.34
Traws Pharma Inc.
NASDAQ: TRAW
TRAW Trading
0.52% G/L:
$1.92 Last:
50,492 Volume:
$1.73 Open:
TRAW Latest News
February 19, 2026 07:30:00 am
Traws Pharma Completes Analysis of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients and Provides Updates for Additional Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza
January 26, 2026 08:30:00 am
Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza
TRAW Stock Data
$15,422,373
6,872,146
2.64%
11
N/A
Biotechnology & Life Sciences
Healthcare
US
Newtown
